Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU
NCT06031038 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 290
Last updated 2026-02-06
Summary
M-TECCU is a study: multicenter, randomized and open. It consists of two parallel groups to compare the efficacy of the TECCU web-based telemonitoring system to achieve and maintain activity remission in patients with moderate-high complexity inflammatory bowel disease compared to usual clinical practice.
Conditions
- Inflammatory Bowel Disease
- Crohn's Disease
- Ulcerative Colitis
- Telemedicine
Interventions
- OTHER
-
TECCU Software
patient monitoring by software application
Sponsors & Collaborators
-
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
lead OTHER
Principal Investigators
-
Mariam Aguas · Spanish Working Group on Crohn's disease and ulcerative colitis (GETECCU)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-15
- Primary Completion
- 2021-10-13
- Completion
- 2025-06-05
Countries
- Spain
Study Locations
More Related Trials
-
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
NCT03668249 ·Status: COMPLETED
-
Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Crohn's Disease
NCT06933264 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease
NCT01860651 ·Status: COMPLETED ·Phase: NA
-
TOD-IBD: Empowering Patients On-Demand
NCT06179563 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases
NCT06742385 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
NCT06954311 ·Status: RECRUITING
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
NCT03710486 ·Status: COMPLETED
-
Evaluation of the Effectiveness of Kits Promonitor-IFX/ADL and Promonitor-Anti-IFX/ADL in Patients With IBD
NCT06666569 ·Status: COMPLETED
-
Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease
NCT03885713 ·Status: COMPLETED ·Phase: PHASE4
-
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
NCT03090139 ·Status: COMPLETED
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Laquinimod Phase IIa Study in Active Crohn's Disease
NCT00737932 ·Status: COMPLETED ·Phase: PHASE2
-
Remote Monitoring of IBD
NCT05886322 ·Status: UNKNOWN
-
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
NCT02622139 ·Status: COMPLETED ·Phase: NA
-
Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment
NCT02622763 ·Status: TERMINATED ·Phase: PHASE1
-
Telephone-based Motivational Interviewing for Smoking Cessation in Crohn's Disease Patients
NCT04225403 ·Status: COMPLETED ·Phase: NA
-
The Use of Web-app Constant-Care in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy
NCT04165265 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
NCT02904590 ·Status: COMPLETED
-
Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease
NCT05874349 ·Status: COMPLETED
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173 ·Status: RECRUITING ·Phase: NA
-
Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease
NCT04896203 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
NCT01369329 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis
NCT05271773 ·Status: COMPLETED
-
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
NCT05499130 ·Status: COMPLETED ·Phase: PHASE2